Skip to the page

Data / Drug companies / Prazosin hydrochloride

Prazosin hydrochloride: 35 companies and 105 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Prazosin hydrochloride is listed in the FDA National Drug Code Directory by 35 companies, with 105 products in commercial distribution. 101 of the products (96.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, and the newest product started marketing on August 4, 2026.

The request: Get every company that lists prazosin hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
35
Products
105
Generic (ANDA) products
101 (96.2%)
Application numbers
10
Routes
Oral
openFDA record search
api.fda.gov

Companies that list prazosin hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Remedyrepack Inc.12capsuleGeneric drugs (ANDA)July 30, 2026
Bryant Ranch Prepack6capsuleGeneric drugs (ANDA)January 3, 2023
Coupler LLC6capsuleGeneric drugs (ANDA)August 4, 2026
Aphena Pharma Solutions - Tennessee, LLC5capsuleGeneric drugs (ANDA)March 31, 2023
Alembic Pharmaceuticals Inc.3capsuleGeneric drugs (ANDA)March 9, 2023
Alembic Pharmaceuticals Limited3capsuleGeneric drugs (ANDA)March 9, 2023
Ani Pharmaceuticals, Inc.3capsuleGeneric drugs (ANDA)October 3, 2018
Asclemed USA, Inc.3capsuleGeneric drugs (ANDA)January 3, 2023
Aurobindo Pharma Limited3capsuleGeneric drugs (ANDA)March 31, 2023
Biocon Pharma Inc.3capsuleGeneric drugs (ANDA)January 9, 2023
Exelan Pharmaceuticals Inc.3capsuleGeneric drugs (ANDA)January 17, 2023
Granules Pharmaceuticals Inc.3capsuleGeneric drugs (ANDA)January 3, 2022
Lifestar Pharma LLC3capsuleGeneric drugs (ANDA)January 3, 2023
Major Pharmaceuticals3capsuleGeneric drugs (ANDA)October 3, 2018
Marlex Pharmaceuticals, Inc.3capsuleGeneric drugs (ANDA)October 1, 2018
Mylan Institutional Inc.3capsuleGeneric drugs (ANDA)October 6, 1998
Mylan Pharmaceuticals Inc.3capsuleGeneric drugs (ANDA)February 28, 1989
Novadoz Pharmaceuticals LLC3capsuleGeneric drugs (ANDA)September 17, 2024
Prasco Laboratories3capsuleAuthorized generics (NDA)March 11, 2022
Preferred Pharmaceuticals Inc.3capsuleGeneric drugs (ANDA)September 23, 2024
Safecor Health, LLC3capsuleGeneric drugs (ANDA)March 25, 2026
Teva Pharmaceuticals USA, Inc.3capsuleGeneric drugs (ANDA)February 22, 2007
A-S Medication Solutions2capsuleGeneric drugs (ANDA)September 17, 2024
American Health Packaging2capsuleGeneric drugs (ANDA)July 12, 2018
Bryant Ranch Prepack2capsuleGeneric drugs (ANDA)February 22, 2007
Cardinal Health 107, LLC2capsuleGeneric drugs (ANDA)May 12, 2022
NCS HealthCare of Ky, LLC DBA Vangard Labs2capsuleGeneric drugs (ANDA)October 3, 2018
PD-Rx Pharmaceuticals, Inc.2capsuleGeneric drugs (ANDA)February 28, 1989
Proficient Rx LP2capsuleGeneric drugs (ANDA)January 3, 2023
St. Mary's Medical Park Pharmacy2capsuleGeneric drugs (ANDA)January 3, 2023
Unit Dose Solutions, Inc.2capsuleGeneric drugs (ANDA)July 1, 2026
American Health Packaging1capsuleGeneric drugs (ANDA)April 21, 2021
NuCare Pharmaceuticals,Inc.1capsuleGeneric drugs (ANDA)January 3, 2023
PD-Rx Pharmaceuticals, Inc.1capsuleGeneric drugs (ANDA)February 28, 1989
Proficient Rx LP1capsuleGeneric drugs (ANDA)January 18, 2007

Dosage forms

Dosage formProductsShare
Capsule105100%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)10196.2%
Authorized generics (NDA)43.8%

Pharmacologic classes

ClassProducts
alpha-Adrenergic Blocker105

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.